Innovent's MSCI ESG Rating Upgraded to A : vimarsana.com

ROCKVILLE, Md. and SUZHOU, China, Nov. 30, 2023 /PRNewswire/ -- Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

Related Keywords

Hong Kong , United States , Suzhou , Jiangsu , China , Huimin , Zhejiang , Taiwan , Macau , Chinese , Adimab Incyte , Innovent Biologics , Eli Lilly , Education Center , China National Reimbursement Drug List , Shu Xin Ke Yi Patient Rescue Program , Incyte Corporation , Good Health , Morgan Stanley Capital International , Treatment Enhancement Training Program , Prnewswire Innovent Biologics Inc , Md Anderson Cancer Center , Hong Kong Stock Exchange , Audit Committee , National Health Commission Capacity Building , United Nations , Southeast Asia , National Reimbursement Drug List , Huimin Insurance Programs , Shu Xin Ke Yi Patient Rescue , Poverty Alleviation , Continuing Education Center , Oncology Standardized Diagnosis , Treatment Enhancement Training , Linkedin Global Best Employer Brand , Universum China , Most Attractive Employers , Sintilimab Injection , Bevacizumab Injection , Adalimumab Injection , Rituximab Injection , Pemigatinib Oral Inhibitor , Ramucirumab Injection , Selpercatinib Capsules , Equecabtagene Autoleucel Injection , Tafolecimab Injection , Cancer Center , Mainland China , Markets ,